Related Experiment Video
Updated: Jun 17, 2026

Development of Recombinant Proteins to Treat Chronic Pain
Published on: April 11, 2018
Insight into pain-inducing and -related gene expression: a challenge for development of novel targeted therapeutic
Ioanna Vasileiou1, Constantinos Giaginis, Chris Klonaris
1Department of Forensic Medicine & Toxicology, Medical School, National & Kapodistrian University of Athens, Athens, Greece.
Abstract:
The multidimensional issue of pain in relation to the need for efficient treatment has been the focus of extensive research. Gaining insight into the molecular mechanisms of pain and identifying specific genes and proteins as possible drug targets is strongly required considering that not all patients can be adequately treated with the currently available drugs. This up-to-date review aimed to summarize the findings of recent proteomic and genomic approaches in different types of pain to comment on their potential role in pain signaling pathways and to evaluate their possible contribution to the development of novel and possibly more targeted pain therapeutic strategies. Although pain treatment strategies have been greatly improved during the past century, no ideal targeted pain treatment has been developed. The development of modern and accurate platforms of technology for the study of genetics and physiology of pain has led to the identification of an increased number of altered genes and proteins that are involved in pain-related pathways. Through genomics and proteomics, pain-related genes and proteins, respectively, may be identified as diagnostic markers or drug targets improving therapeutic strategies. Furthermore, such molecular mediators of pain may reveal novel strategies for individualized pain management. The utilization of unique experimental approaches (through specific animal models) as well as powered genetic association studies conducted on appropriate populations is more than essential.
Insights
Genomic and proteomic research is identifying new pain targets. These molecular insights could lead to more effective, individualized pain treatments for patients unresponsive to current therapies.
Area of Science:
- Neuroscience
- Genetics
- Molecular Biology
Background:
- Pain management remains a significant challenge, with current treatments inadequately addressing all patient needs.
- Identifying molecular mechanisms underlying pain is crucial for developing targeted therapies.
- Advances in technology necessitate an updated review of proteomic and genomic findings in pain research.
Purpose of the Study:
- To review recent proteomic and genomic studies on various pain types.
- To analyze the role of identified genes and proteins in pain signaling pathways.
- To evaluate the potential of these findings for novel pain therapeutic strategies.
Main Methods:
- Comprehensive literature review of proteomic and genomic approaches in pain research.
- Analysis of identified genes and proteins involved in pain-related pathways.
- Evaluation of experimental approaches, including animal models and genetic association studies.
Main Results:
- Genomics and proteomics have identified numerous genes and proteins implicated in pain pathways.
- These molecular mediators offer potential as diagnostic markers and drug targets.
- Novel therapeutic strategies for individualized pain management are emerging.
Conclusions:
- Proteomic and genomic research is vital for advancing pain management.
- Identifying molecular targets can improve the efficacy and specificity of pain treatments.
- Future research should focus on robust experimental designs and population studies for clinical translation.
Related Concept Videos
Analgesia and Pain Management
Pharmacogenomics: Identification of New Drug Targets
Nociception
Pain
